Bristol-Myers Squibb Co (BMY)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$52.41
Buy
$52.50
$1.21 (+2.36%)
Prices updated at 13 Dec 2025, 00:52 EST
| Prices minimum 15 mins delay
Prices in USD
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 71.08 |
| 2023 | 76.24 |
| 2022 | 78.04 |
| 2021 | 78.57 |
| 2020 | 72.31 |
| 2019 | 69.10 |
| 2018 | 71.34 |
| 2017 | 71.05 |
| 2016 | 74.42 |
| 2015 | 76.39 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 2.22 |
| 2024 | 2.42 |
| 2023 | 2.40 |
| 2022 | 3.34 |
| 2021 | 3.06 |
| 2020 | 3.47 |
| 2019 | 4.34 |
| 2018 | 3.86 |
| 2017 | 4.95 |
| 2016 | 5.32 |
| 2015 | 6.98 |
Price/Forward earnings (YTD)
8.67
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -9.53 |
| 2023 | 8.36 |
| 2022 | 6.14 |
| 2021 | 6.14 |
| 2020 | -7.26 |
| 2019 | 4.17 |
| 2018 | 14.36 |
| 2017 | 2.99 |
| 2016 | 13.62 |
| 2015 | 4.78 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 5.67 |
| 2023 | 3.23 |
| 2022 | 3.12 |
| 2021 | 3.04 |
| 2020 | 3.13 |
| 2019 | 2.52 |
| 2018 | 2.49 |
| 2017 | 2.86 |
| 2016 | 2.08 |
| 2015 | 2.23 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
